PMID: 4899874Jul 1, 1969Paper

Interferon synthesis in x-irradiated animals. IV. Donor-type serum interferons in rat-to-mouse radiation chimeras injected with Newcastle disease virus

Proceedings of the National Academy of Sciences of the United States of America
J De Maeyer-GuignardP Jullien

Abstract

C(3)H/He mice were exposed to total-body X-irradiation of 1000 roentgens and received thereafter 10(7) xenogeneic Wistar rat marrow cells intravenously. In these rat-to-mouse chimeras, serum interferon-producing capacity upon injection of Newcastle disease virus was examined four weeks after grafting. Normal levels of circulating interferon were produced. The interferon, however, had the species specificity of rat interferon, being 20 times more active in rat embryo fibroblasts than in mouse embryo fibroblasts. Moreover, it behaved like rat interferon when filtered on Sephadex G-100 dextran gel, displaying one peak of activity in the 90,000 molecular-weight range and two incompletely separated peaks of 32,000 and 24,000, respectively, in the 30,000 molecular-weight region. The fact that the interferon is of the donor type in rat-to-mouse chimeras permits us to conclude that circulating interferon induced by New-castle disease virus is made in bone-marrow-derived cells.

References

May 1, 1968·The Journal of General Virology·E De Maeyer, J De Maeyer-Guignard
Feb 28, 1966·Biochimica Et Biophysica Acta·E Schonne
Apr 1, 1967·The Journal of Experimental Medicine·T J Smith, R R Wagner
Sep 12, 1957·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·A ISAACS, J LINDENMANN
Feb 1, 1959·Proceedings of the Society for Experimental Biology and Medicine·I C SHEKARCHI, T MAKINODAN
Mar 1, 1964·Journal of General Microbiology·G E GIFFORDE HELLER
Sep 1, 1964·Virology·E DEMAEYER, E SCHONNE

❮ Previous
Next ❯

Citations

Mar 4, 1999·Journal of the Neurological Sciences·L DurelliG Aimo
Jun 8, 2002·Veterinary Immunology and Immunopathology·Elin JohanssonC Fossum
Jul 6, 1972·The New England Journal of Medicine·S E Grossberg
Jul 1, 1997·Journal of Neuroimmunology·K G BeckerW E Biddison
Aug 17, 2000·The Journal of Infectious Diseases·S N Han, S N Meydani
Jan 1, 1980·Annals of the New York Academy of Sciences·E De Maeyer, J De Maeyer-Guignard
Jan 27, 1971·Nature: New Biology·E De MaeyerI Montagnier
Feb 17, 1971·Nature: New Biology·J de Maeyer-Guignard, E de Maeyer
Oct 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·Blaire L OsbornCynthia Sung
May 19, 2010·Laboratory Investigation; a Journal of Technical Methods and Pathology·Correne A DeCarloIngeborg Zehbe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
J DesmyterJ L Melnick
Transactions of the New York Academy of Sciences
S GraffO Kastner
© 2021 Meta ULC. All rights reserved